Mattson Financial Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Buy
1,941
+46
+2% +$6.9K 0.06% 202
2026
Q1
$289K Buy
+1,895
New +$290K 0.07% 180
2025
Q2
Sell
-12
Closed -$1.34K 292
2025
Q1
$1.34K Buy
+12
New +$1.28K ﹤0.01% 298

Other funds holding NVS

Mattson Financial Services's NVS Position: Q2 2026 in Review

Mattson Financial Services increased its Novartis (NVS) stake by 2.4% in Q2 2026, buying an estimated $6.9K and bringing the position to 1,941 shares worth $296K. The position accounts for 0.06% of the portfolio, ranked #202.

Mattson Financial Services first reported a position in NVS in Q1 2025 and has held it in 3 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Mattson Financial Services held 1,941 shares of Novartis worth $296K as of Q2 2026.
  • Mattson Financial Services bought 46 Novartis shares in Q2 2026, an estimated $6.9K.
  • Novartis made up 0.06% of Mattson Financial Services's portfolio in Q2 2026, its #202 holding.
  • Mattson Financial Services first reported a position in Novartis in Q1 2025 and has held it in 3 quarters since.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Mattson Financial Services's 13F filing for Q2 2026, filed 4 Aug 2026.